MAP2K4 and hepatocellular carcinoma: Interleukin-6 can activate the MAP3K upstream kinase MKK4 for the Jun N-terminal kinase (JNK) in human HepG2 hepatoma cells [135], a signaling pathway well known to regulate several normal biological processes, not solely stress-related responses.